Table 4.
Urologists’ Level of Interest in Training to Administer Interleukin-2 (IL-2) to Patients with Renal Cell Carcinoma
| % of | |
|---|---|
| Level of Interest | Urologists |
| Extremely high | 10 |
| High | 18 |
| Low | 25 |
| Extremely low | 42 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.